- 15k views
Management of Hyperbilirubinemia in the Newborn Infant
Hyperbilirubinemia is a common condition in newborn infants, and its management is crucial to prevent severe complications such as kernicterus. The American Academy of Pediatrics (AAP) has published guidelines for the management and prevention of hyperbilirubinemia in newborn infants ≥35 weeks’ gestation. Infants with risk factors for hyperbilirubinemia require closer monitoring than infants without risk factors. Determining the presence of these risk factors requires examining the infant, assessing laboratory data, and obtaining a family history of blood disorders or neonatal jaundice. Phototherapy is an effective treatment for hyperbilirubinemia, but the number needed to treat varies widely depending on sex, gestational age, and other factors.
About the Speaker
Dr. Vishal Parmar
Consultant Critical Care , Apollo Hospitals, Mumbai
Dr. Vishal Parmar is a trained Pediatrician with extensive experience in General Pediatrics in NewBorn care & adolescent health.
Watch Next
Mycoplasma Pneumonias outbreak
Mycoplasma pneumonia is a bacterium causing respiratory infections, often manifesting as atypical pneumonia. Periodic outbreaks occur in communities, especially in crowded settings like schools and military barracks. The bacterium spreads through respiratory droplets, with close person-to-person contact facilitating its transmission. Symptoms include persistent cough, fever, fatigue, and occasionally extrapulmonary manifestations like skin rashes. Mycoplasma pneumonia commonly affects children and young adults, but individuals of any age can be susceptible. Diagnosing mycoplasma pneumonia can be challenging due to atypical symptoms, often requiring specific laboratory tests. Antibiotics such as macrolides or tetracyclines are prescribed for effective treatment, although some cases may resolve without specific therapy. Implementing respiratory hygiene practices, especially in crowded environments, can help prevent outbreaks. Outbreaks may trigger public health responses, including surveillance, education, and appropriate antibiotic use to control the spread of Mycoplasma pneumonia.
Pediatric Immunization Strategies
Vaccination schedules are carefully designed to provide immunity when children are most vulnerable.Immunizations are administered in a series to ensure full protection over time. Combination vaccines streamline the process, reducing the number of shots required. Herd immunity, achieved when a significant portion of the population is vaccinated, helps protect those who cannot be vaccinated, such as newborns and individuals with certain medical conditions. Vaccines are rigorously tested for safety and efficacy before approval. Vaccination catch-up schedules are available for children who missed earlier immunizations. Regular booster shots are given to reinforce immunity and maintain protection.
Management of Viral Infection in Children
Managing viral infections in children involves a holistic approach to ensure a swift and effective recovery while minimizing the risk of complications. Maintaining proper hydration is essential. Encourage frequent sips of water, clear fluids, or oral rehydration solutions to prevent dehydration, especially when there is fever, vomiting, or diarrhea. Adequate rest allows the child's immune system to work efficiently. Ensure they get plenty of sleep during their illness. Over-the-counter fever-reducing medications like acetaminophen or ibuprofen can help manage fever and discomfort. Always follow dosing guidelines and consult a healthcare provider if needed. Keep the child isolated to prevent the spread of the virus to others. This is particularly crucial for highly contagious illnesses like influenza or COVID-19. Encourage a balanced diet to support the child's immune system. If they have a reduced appetite, offer smaller, more frequent meals. Teach children proper handwashing techniques to prevent the spread of the virus to themselves and others. Managing viral infections in children requires a combination of supportive care, appropriate medications, and close monitoring. Always consult with a healthcare provider for guidance, especially if the child's condition is severe or not improving as expected.
Approach to Case of Ataxia in Children
Ataxia in children is a neurological disorder characterized by impaired coordination, balance, and voluntary muscle movements. Ataxia is a term used to describe a group of disorders that affect the cerebellum, a part of the brain responsible for coordination and balance. There are various types of ataxia in children, including hereditary ataxias (genetic), acquired ataxias (due to injury or illness), and idiopathic ataxia (of unknown cause). Common symptoms include unsteady gait, tremors, difficulty with fine motor skills, slurred speech, and problems with eye movements. Hereditary ataxias often result from genetic mutations, while acquired ataxias may be caused by brain injuries, infections, or toxins. Diagnosis involves a thorough medical history, physical examination, neurological tests, and imaging studies like MRI or CT scans to assess the brain's condition. Management depends on the underlying cause. Symptomatic treatment may include physical and occupational therapy to improve motor skills and assistive devices for mobility. In cases of hereditary ataxia, genetic counseling is essential to assess the risk of passing on the condition to future generations. The prognosis varies based on the type and severity of ataxia. Some forms may be progressive, while others remain stable or improve with therapy.
Invasive Meningococcal disease and its prevention in children
Invasive Meningococcal Disease (IMD) is a severe infection caused by the bacterium Neisseria meningitidis, leading to potentially life-threatening conditions such as meningitis (inflammation of the brain and spinal cord membranes) and bloodstream infections. Symptoms often include high fever, severe headaches, neck stiffness, and sensitivity to light. Rapid medical attention is crucial due to the swift progression of the disease and its potential for serious complications. Preventive measures such as vaccines are important in controlling its spread.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr. Vishal Parmar 's Talks on Assimilate
- 17th-October-2023, TIME : 05:00PM - 06:00PM
- 0
Hyperbilirubinemia is a common condition in newborn infants, and its management is crucial to prevent severe complications such as kernicterus. The American Academy of Pediatrics (AAP) has published guidelines for the management and prevention of hyperbilirubinemia in newborn infants ≥35 weeks’ gestation. Infants with risk factors for hyperbilirubinemia require closer monitoring than infants without risk factors. Determining the presence of these risk factors requires examining the infant, assessing laboratory data, and obtaining a family history of blood disorders or neonatal jaundice. Phototherapy is an effective treatment for hyperbilirubinemia, but the number needed to treat varies widely depending on sex, gestational age, and other factors.
- 17th-October-2023, TIME : 05:00PM - 06:00PM
- 0
Hyperbilirubinemia is a common condition in newborn infants, and its management is crucial to prevent severe complications such as kernicterus. The American Academy of Pediatrics (AAP) has published guidelines for the management and prevention of hyperbilirubinemia in newborn infants ≥35 weeks’ gestation. Infants with risk factors for hyperbilirubinemia require closer monitoring than infants without risk factors. Determining the presence of these risk factors requires examining the infant, assessing laboratory data, and obtaining a family history of blood disorders or neonatal jaundice. Phototherapy is an effective treatment for hyperbilirubinemia, but the number needed to treat varies widely depending on sex, gestational age, and other factors.
- 17th-October-2023, TIME : 05:00PM - 06:00PM
- 0
Hyperbilirubinemia is a common condition in newborn infants, and its management is crucial to prevent severe complications such as kernicterus. The American Academy of Pediatrics (AAP) has published guidelines for the management and prevention of hyperbilirubinemia in newborn infants ≥35 weeks’ gestation. Infants with risk factors for hyperbilirubinemia require closer monitoring than infants without risk factors. Determining the presence of these risk factors requires examining the infant, assessing laboratory data, and obtaining a family history of blood disorders or neonatal jaundice. Phototherapy is an effective treatment for hyperbilirubinemia, but the number needed to treat varies widely depending on sex, gestational age, and other factors.